This product is for research use only, not for human use. We do not sell to patients.
Size | Price |
---|---|
250mg | Get quote |
500mg | Get quote |
1g | Get quote |
Cat #: V41554 CAS #: 2227211-00-7 Purity ≥ 99%
Description: Milrebrutinib (AS-1763) is a novel, next-generation and noncovalent BTK (Bruton's Tyrosine Kinase) inhibitor with anticancer and anti-inflammatory activity. BTK has been recognized as a validated drug target for the treatment of B-cell malignances, the emergence of clinical resistance to the first-generation covalent BTK inhibitors is becoming a serious concern. With significant efficacies in vivo tumor xenograft models, Milrebrutinib (AS 1763) has been advanced to phase 1 clinical trials. Reference: A Potent, Selective, Noncovalent, and Orally Available Inhibitor of Bruton's Tyrosine Kinase. J Med Chem. 2021 Oct 14;64(19):14129-14141.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Formula | C33H31FN6O3 |
---|---|
CAS No. | 2227211-00-7 |
SMILES Code | O=C1N(C2=C(CO)C(C3=NC(N)=NC4=C3C=C(C5=CCN(C6COC6)CC5)N4)=CC=C2)C=CC7=CC(C8CC8)=CC(F)=C71 |
Synonyms | Milrebrutinib; AS1763; ASA-1763; AS 1763; ASA1763; AS-1763; ASA 1763 |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.